361 Managed Futures Strategy Fund Receives Top Morningstar

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
73
361 Managed Futures Strategy Fund Receives Top Morningstar Rating

DENVER, Feb. 08, 2017 (GLOBE NEWSWIRE) -- 361 Capital, a leading boutique asset manager offering distinctive investment strategies to institutions, investment advisors and their clients, today announced its 361 Managed Futures Strategy Fund (AMFZX), received a five‐star Morningstar Rating TM based on risk-adjusted returns as of December 31, 2016, among 55 funds in the managed futures category for the five year period. The Fund received a four-star Overall Morningstar Rating TM as of December 31, 2016, among 103 funds in the managed futures category.

With political uncertainty and the potential for economic trade wars feeding investor fears, the Fund’s counter‐trend approach is tailor-made for today’s markets. Its proprietary investment methodology incorporates behavioral investing measures, identifying periods when fear and greed are present and attempts to profit from these emotions. The strategy’s short investment horizon and contrarian objective give it a low correlation to broad markets and other managed futures products.

“Markets are always full of surprises and as the start of 2017 has shown, investors need to be prepared for increased market volatility,” said Cliff Stanton, Chief Investment Officer of 361 Capital. “We believe our five-star rating is validation of our distinct investment approach, which historically has generated consistent risk‐adjusted returns in choppy markets for our clients.”

A true diversifier—without hidden fees With a correlation of 0.02 to the market since inception* and a beta of 0.01 during this same time frame through December 31, 2016, the 361 Managed Futures Strategy Fund aims to provide true diversification for a portfolio. It invests primarily in long and short positions in equity index futures contracts and does not have hidden fees from so-called total-return swaps or “2 and 20” fee structures. It’s also one of only two counter‐trend strategies in the managed futures category—the other being the 361 Global Counter-Trend Fund.

“We’ve built the 361 Managed Futures Strategy Fund to provide true portfolio diversification and downside risk management, while seeking to generate attractive returns over time,” said Stanton. “As the U.S. settles into the first 100 days of the Trump Administration, the environment is ripe for advisors to incorporate managed futures into client portfolios. Our Fund, with its proven five-year track record, can help address client fears and market uncertainty.”

For more information about the 361 Managed Futures Strategy Fund or questions about implementing to alternative investment products, contact 866‐361‐1720.

About 361 Capital 361 Capital is an award-winning** boutique asset manager focused on delivering an array of distinctive strategies to institutions, advisors and their clients. Founded in 2001, the Firm specializes in creating innovative portfolio solutions using behavioral-driven, quantitative methods designed to monetize behavioral biases and market factors in order to pursue consistent alpha for client portfolios.

361 Capital is majority employee-owned with strategic investments from Lovell Minnick Partners, a private equity firm and Lighthouse Investment Partners. For more information, call 866.361.1720 or visit 361capital.com.

*Fund inception was December 20, 2011 and monthly correlation and beta information became available on January 1, 2012. (Beta measures a fund’s sensitivity to market movements. The beta of a market is 1.00 by definition.)

**Awards: WealthManagement.com 2016 Industry Awards, Winner Alternatives Asset Manager, http://awards.wealthmanagement.com . The WealthManagement.com Industry Awards recognizes the alternatives asset manager that has made an ‘outstanding contribution’ in adding a new initiative/program or enhancing an existing platform that improves advisors’ understanding, usage, & portfolio management of alternatives.

You should consider the Fund’s investment objectives, risks, charges and expenses carefully before investing. For a  prospectus , or summary prospectus, that contains this and other information about the Funds, call 1-888-736-1227. Please read the prospectus or summary prospectus carefully before investing.

Investing involves risk, including possible loss of principal. Futures prices may be very volatile. The small margin required for futures contracts magnifies the effect of market volatility and allows the loss from a contract potentially to exceed the Fund’s initial investment. With short contracts, the loss is theoretically unlimited since the appreciation of the underlying asset also is theoretically unlimited. Fund assets not invested in futures are invested primarily in investment-grade bonds. Bond prices generally fall when interest rates rise. Frequent trading by the Fund may reduce returns and increase the number of taxable transactions. Concentration of its portfolio in relatively few issuers may make the Fund more volatile than a diversified fund.

** The Morningstar Rating™ for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk- Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods. The Fund received 3 stars of out 103 funds for the 3-year period as of 12/31/16. Past performance is no guarantee of future results.

© 2017 Morningstar, Inc. All Rights Reserved.

The 361 Funds are distributed by IMST Distributors, LLC.

For press inquiries, contact: Mo Shafroth 720-470-3653 mo.shafroth@shafroth.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 5

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 5

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Arch Capital Group Achieves $978 Million in Q3 Earnings

Updated Category News Views 135

Arch Capital Group Reports Third Quarter Financial Success Arch Capital Group Ltd. (NASDAQ: ACGL) recently announced strong financial results for the third quarter. This report signifies a remarkable achievement for the company as it reflects the overall financial health and operational efficiency across its diverse business segments. Strong Financial Performance The net...

Continue Reading
Unleashing Potential: BexBack's Innovative Crypto Trading

Updated Category News Views 131

Welcome to the New Era of Cryptocurrency Trading with BexBack The cryptocurrency market is known for its unpredictability, and with Bitcoin's price teetering around $100,000, many traders find themselves navigating a landscape filled with uncertainty. In such a turbulent environment, seasoned investors are increasingly turning to futures trading with 100x leverage to...

Continue Reading
MasHash Unveils Revolutionary Cloud Mining Platform

Updated Category News Views 292

MasHash Launches Innovative Cloud-Based Mining Platform MasHash, a prominent provider of cloud-based cryptocurrency mining solutions, has unveiled its latest and improved mining platform. This new offering aims to revolutionize how users participate in crypto mining and enhance their profitability. The Growing Significance of Crypto Mining in 2024 As we enter 2024, the...

Continue Reading
Syndax Pharmaceuticals Plans Engaging Investor Event Soon

Updated Category News Views 29

Investor Event Scheduled for December Syndax Pharmaceuticals (Nasdaq: SNDX), a pioneering biopharmaceutical company renowned for its cutting-edge cancer treatments, has announced an upcoming investor event. This event will allow attendees to engage directly with the Syndax team and learn more about the groundbreaking research being conducted in the field of oncology....

Continue Reading
Introducing Seguritech's Smartwatch for Safety and Health Monitoring

Updated Category News Views 178

Introducing Seguritech's Innovative Smartwatch Seguritech has taken a bold step in personal safety with the introduction of its Early Warning Smartwatch. This remarkable device connects users seamlessly to a network of Command and Control Centers, ensuring immediate access to emergency responders in critical situations. Key Features of the Early Warning Smartwatch The...

Continue Reading